Early Graft Dysfunction After Living Donor Kidney Transplant
Ideally, immediate graft function should be expected after living donor kidney transplantation. We present a case of early Banff 2A cellular rejection 24 hours after an ABO blood group-compatible, HLA crossmatch-negative living donor kidney transplant. We speculate that the development of acute rejection in this low-risk patient was likely due to the HLA mismatches and possible induction with basiliximab. This case report poses the question of whether more intensive induction therapy should be considered in low-risk patients with the presence of HLA mismatches and discusses the long-term allograft outcomes following early acute rejection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation - 20(2022), 4 vom: 02. Apr., Seite 425-428 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sharma, Neeraj [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 28.04.2022 Date Revised 22.06.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.6002/ect.2020.0446 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM324315546 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM324315546 | ||
003 | DE-627 | ||
005 | 20231225190047.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.6002/ect.2020.0446 |2 doi | |
028 | 5 | 2 | |a pubmed24n1081.xml |
035 | |a (DE-627)NLM324315546 | ||
035 | |a (NLM)33877034 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sharma, Neeraj |e verfasserin |4 aut | |
245 | 1 | 0 | |a Early Graft Dysfunction After Living Donor Kidney Transplant |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.04.2022 | ||
500 | |a Date Revised 22.06.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Ideally, immediate graft function should be expected after living donor kidney transplantation. We present a case of early Banff 2A cellular rejection 24 hours after an ABO blood group-compatible, HLA crossmatch-negative living donor kidney transplant. We speculate that the development of acute rejection in this low-risk patient was likely due to the HLA mismatches and possible induction with basiliximab. This case report poses the question of whether more intensive induction therapy should be considered in low-risk patients with the presence of HLA mismatches and discusses the long-term allograft outcomes following early acute rejection | ||
650 | 4 | |a Case Reports | |
650 | 7 | |a ABO Blood-Group System |2 NLM | |
650 | 7 | |a HLA Antigens |2 NLM | |
700 | 1 | |a Cao, Thanh |e verfasserin |4 aut | |
700 | 1 | |a Bajwa, Ranvir |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation |d 2003 |g 20(2022), 4 vom: 02. Apr., Seite 425-428 |w (DE-627)NLM155078615 |x 2146-8427 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2022 |g number:4 |g day:02 |g month:04 |g pages:425-428 |
856 | 4 | 0 | |u http://dx.doi.org/10.6002/ect.2020.0446 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2022 |e 4 |b 02 |c 04 |h 425-428 |